Project Grant R01AI198975
- This federal Project Grant award of $1,442,898.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to study the effects of vaccination on outcomes of acute and post-acute respiratory viral infections, including COVID-19, in solid organ transplant recipients. The research aims to better understand the risks of severe respiratory viral infections and associated post-acute syndromes...
- This $444,125 federal Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Duke University. The funding supports research to simultaneously target immunoglobulin G and M antibodies using an endopeptidase enzyme, with the goal of overcoming humoral rejection in xenotransplantation. The research aims to provide a mechanistic explanation and intervention for the consistent early...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,273,991 Cooperative Agreement to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The funding supports research to investigate the physiology and early immune responses to genetically modified porcine liver xenografts using a human brain-dead donor...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,486 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The purpose of this 20-month grant, with a period of performance from September 2025 to April 2027, is to identify metabolic targets that could reinvigorate exhausted T cells and enhance their function against viruses, bacteria, and tumors. The research aims to elucidate how chronic T cell...
- This federal Project Grant award of $125,596 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a 5-year research and mentorship program led by Dr. Ali Zarrinpar at the University of Florida. The research aims to integrate methodology from model systems with human samples to learn how to use metabolic modulation to affect the immune response to ischemia-reperfusion injury, a major source of graft injury during organ...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $212,169 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to The Johns Hopkins University to advance mentorship at the Johns Hopkins Integrated Center for Combating Antimicrobial Resistant Bacteria. The project summary indicates the principal investigator has conducted pivotal research on antimicrobial resistant infections, leading to clinical guidelines, and has...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $153,512 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Leland Stanford Junior University. The grant will fund research to characterize the renal immune microenvironment in antibody-mediated rejection (ABMR) of kidney transplants in order to develop improved diagnostics and predict treatment response. The research will utilize advanced imaging mass cytometry to profile...
- This Project Grant award of $3,145,850.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program. The award supports research at The Johns Hopkins University to investigate macrophage senescence as a driver of granuloma failure and necrosis in pulmonary tuberculosis (TB) and TB/HIV coinfection. Key objectives include understanding the role of stress-induced senescence in myeloid...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a 5-year, $1,546,730 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to support the continuation and expansion of the Johns Hopkins HIV Implementation Science Hub (Hopkins Hub). The key objectives of this award are to: 1) enhance the technical rigor of implementation science research and build capacity among investigators focused on ending...
- This federal Project Grant award, valued at $155,227.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The project aims to generate proof-of-concept data on a novel strategy to treat Mycobacterium abscessus (MAB) chronic lung disease, which currently has no FDA-approved treatments. The strategy involves using a biofilm disruptor as an adjunct to antibiotics to more effectively...
This federal Project Grant award of $1,031,754.00, awarded on September 2, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research), supports research at The Johns Hopkins University to develop clinically relevant pharmacologic and immunomodulatory strategies to achieve long-term survival of kidney xenografts in primates. The research aims to advance understanding and treatment of infectious diseases and immune system disorders, with a focus on innovative approaches to organ transplantation. As a leading federal research institution, The Johns Hopkins University has demonstrated extensive expertise in delivering complex biomedical research services to government agencies, making it well-positioned to execute this project over the next 5 years through August 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.0m | 9/2/25 |